Is marijuana unhealthy? In this video, Mic. the Vegan reviews over 20 studies on the topic to determine which myths and claims about marijuana’s harms and benefits are valid.
Tag Archives: Research
On Sept. 21, 2017, the Tennessee medical cannabis task force, created by Lt. Gov. Randy McNally and State House Speaker Beth Harwell, met for the first time to discuss legalization.
PORTLAND, Ore., Sept. 20, 2017 /Weed Wire/ — An Oregon Health Authority (OHA) education campaign aimed at youth and young adults raised awareness among its target audience of the risks associated with marijuana use, an independent evaluation has found.
CHICAGO, Sept.18, 2017 /Weed Wire/ – A bipartisan group of senators led by Brian Schatz (D-Hawaii) has reintroduced the Marijuana Effective Studies Act of 2016 (MEDS Act), which will remove excessive regulatory barriers inhibiting researchers from obtaining marijuana plants to conduct studies assessing the drug’s medical effectiveness and safety.
Last November, California voters approved a ballot measure to legalize marijuana. Now, the state’s lawmakers are formally calling on the federal government to reclassify marijuana.
WASHINGTON, Sept. 14, 2017 /Weed Wire/ — Senator Cory Gardner (R-CO) introduced the Marijuana Effective Drug Study (MEDS) Act of 2017 to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment.
WASHINGTON, Sept. 14, 2017 /Weed Wire/ — Senator Cory Gardner (R-CO) introduced the Marijuana Effective Drug Study (MEDS) Act of 2017 to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment. The legislation’s lead sponsor was Senator Orrin Hatch (R-UT).
On Sept. 13, 2017, U.S. Sen. Orrin Hatch, R-Utah, introduced legislation to cut the bureaucratic red tape thwarting medical cannabis research so health care professionals can harness the medicinal properties of the plant to reduce the suffering of patients in need.
WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Today, Senator Thom Tillis (R-NC) joined Senators Brian Schatz (D-HI), Orrin Hatch (R-UT), Cory Gardner (R-CO) and Chris Coons (D-DE) to introduce the Marijuana Effective Drug Studies (MEDS) Act of 2017, bipartisan legislation that would make it easier for researchers to study the medical effectiveness and safety of marijuana.
PERTH, Australia, Sept. 13, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it is making significant progress with its research programme in Chile.
WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Senator Orrin Hatch (R-UT), a member and former Chairman of both the Senate Judiciary Committee and the Senate Health, Education, Labor and Pensions Committee, will speak on the Senate floor today about medical marijuana research and the possible benefits of medical marijuana as an alternative to opioids. The speech will take place at 3:30 on the Senate floor.
WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Today, Senator Orrin Hatch (R-UT) introduced the Marijuana Effective Drug Study Act of 2017, or MEDS Act, to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment. In introducing this legislation, Senator Hatch was joined by Senator Schatz (D-HI) and cosponsors Senator Chris Coons (D-DE), Senator Cory Gardner (R-CO), and Senator Thom Tillis (R-NC).
On Sept. 7, 2017, Gov. Phil Scott signed Executive Order 15-17, officially launching the Vermont Marijuana Advisory Commission. The commission will explore several options concerning how to successfully legalize recreational marijuana in the state.
The “gateway theory,” the theory that cannabis use leads to the use of harder drugs, has been debunked once again by academia.
Governor Phil Scott today issued Executive Order 15-17, establishing the Governor’s Marijuana Advisory Commission, charged with recommending a comprehensive approach to addressing health, safety, regulatory and infrastructure needs when considering legalized marijuana use.
CANTANHEDE, Portugal, Sept. 7, 2017 /Weed Wire/ – Tilray, a global pioneer in medical cannabis research and production, announced plans today to invest up to €20 million in a European Union Campus (EU Campus) after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes.
Louisiana State University has selected its medical marijuana vendor and now LSU Health Shreveport is ready to prepare for Louisiana medical marijuana research.
NEW PALTZ, NY, Sept. 8, 2017 /Weed Wire/ — The Benjamin Center for Public Policy Initiatives at SUNY New Paltz has released its 18th discussion brief, “The Marijuana Gateway Fallacy.” The brief marshals extensive social science evidence to show that the idea that marijuana use is a “gateway” to the use of harder drugs is a myth.
Washington has one more statistic to support the legalization of recreational cannabis in the Evergreen State: Washington youth cannabis use hasn’t increased since the enactment of Initiative 502, the measure that legalized recreational cannabis in the state.
OTTAWA, Ontario, Aug. 31, 2017 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced that it will benefit from the intellectual property (IP) created within the cannabis health research Chair (The Chair) from the University of New Brunswick (UNB).
On Aug. 6, 2017, Sue Sisley, M.D., sent a letter to Secretary of Veterans Affairs David Shulkin to request that he stop a Phoenix hospital’s obstruction of the first clinical trial to study the effects of medical cannabis in the treatment of post-traumatic stress disorder in military veterans.
PALM BEACH, Fla., Aug. 30, 2017 /Weed Wire/ — More than 200 high-net worth investors from around the world, eager to invest in the fastest growing industry in America will gather at the Eau Palm Beach Resort & Spa for a two day “Shark Tank”-like pitch forum on Tuesday, September 19th and Wednesday, September 20th, hosted exclusively for members of The Arcview Investor Network.
Research into the potential medical uses of marijuana compounds continues apace. Among the most recent, a study delved into why marijuana is an effective stress reducer.
Marijuana use has little to no effect on kidney function in healthy young adults. This is according to a new study published in the Clinical Journal of the American Society of Nephrology on Aug, 24, 2017.
NEW YORK, Aug. 24, 2017 /Weed Wire/ — The National Institute of Health has awarded a $3.8 million research grant to Albert Einstein College of Medicine and Montefiore Health System for medical marijuana research, and Vireo Health of New York will be partners in the study.
HARRISBURG, Penn., Aug. 17, 2017 /Weed Wire/ — Agriculture Secretary Russell Redding visited two of 14 research projects that seek to demonstrate the economic value and viability of industrial hemp as a marketable crop in Pennsylvania.
Smoking marijuana may reduce your risk of having a stroke, according to a new study published in the journal Neuropsychopharmacology.
The Massachusetts Medical Society has developed a marijuana training program for doctors so they can openly talk with their patients about it.
Even though pain and posttraumatic stress disorder (PTSD) are among the most common reasons people use medical marijuana in the U.S., there isn’t much proof cannabis works for either one of these conditions, two research reviews suggest.
LAS VEGAS, Aug. 15, 2017 /Weed Wire/ — Freedom Leaf, Inc. (OTCQB: FRLF) has joined forces with WallStreet Research (WSR) to be the Financial Go-To organizations for public companies to aid in Financial Research Reports and Marijuana/Hemp Investment and information Forums in LA, San Francisco, Boca Raton, FL and NYC throughout the year.
TORONTO, Ontario, Aug. 14, 2017 /Weed Wire/ — A new report by the Canadian Mental Health Association (CMHA) Ontario Division offers the provincial government wide-ranging recommendations to reduce the health risks and harms associated with the legalization and regulation of cannabis.
The NFL’s chief medical officer says it is “really important” for the league and the NFL Players Association to determine whether marijuana can be used as an effective and safe pain-management tool for players.
The NFL has written to the NFL Players Association offering to work in tandem to study the potential use of marijuana as a pain management tool for players, according to people familiar with the situation.
PERTH, Australia, July 31, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has expanded its research collaboration with Complutense University.
Colorado’s legal recreational cannabis sales commenced in 2014, but not every municipality chose to embrace the retail market, so a Colorado Springs retail cannabis market has yet to materialize; however, some citizens are looking to change that.
The number of Americans that have tried marijuana has hit an all time high. According to a recent Gallup poll, approximately 45% of Americans have tried marijuana, marking a record high since the polling organization began asking the question in 1969.
Cannabis may be California’s largest cash crop, but dispensaries who sell the profitable plants haven’t always reaped their rewards.
MILWAUKEE, Wisc., July 19, 2017 /Weed Wire/ — Marijuana is quickly becoming a legal multi-billion dollar industry in the United States, prompting new research into multiple aspects of the drug, including both use and production.
WASHINGTON, July 17, 2017 /Weed Wire/ — A meeting scheduled by the President’s Commission on Combating Drug Addiction and the Opioid Crisis for this afternoon has been postponed until July 31, 2017.
At a secret location in Australia’s southeast, Peter Crock delicately tends to a two-month-old cannabis cutting. Barely knee high, it is one of about 50 government-sanctioned “mother plants” to be cloned for future generations of crops for the country’s fledgling medicinal marijuana industry.
An often held assumption about medical marijuana dispensaries is that they are a magnet for drugs, violence and crime; however, a new study in the Journal of Urban Economics turns that assumption on its head.
Growing marijuana is illegal in Utah and so is growing hemp — which is a close relative of pot. But, that could change. This week, the Utah agriculture department proposed allowing anyone to grow it with proper certification.
Gov. Andrew Cuomo has signed legislation that aims to boost hemp production, as Ontario gathers public input on legalizing marijuana.
SAN FRANCISCO, July 12, 2017 /Weed Wire/ — Canna Angels LLC, a leading angel investment consortium focused on opportunities within the cannabis industry, today announced that RET. California State Senator Joe Dunn and Dr. Daniele Piomelli, PhD, Pharm.D., will be featured guests at the Canna Angels July 19 Founders Showcase.
NEW YORK, July 11, 2017 /Weed Wire/ — A new report released today by the Marijuana Arrest Research Project, commissioned by the Drug Policy Alliance, shows that marijuana possession arrests under Mayor de Blasio continue to be marked by extremely high racial disparities, as was the case under the Bloomberg and Giuliani administrations.
On June 20, 2017, Battelle, an Ohio-based non-profit research and development organization that has studied tobacco for the past 50 years, announced that it would be expanding its research efforts to include marijuana and opioids.
On June 19, 2017, Mexican President Enrique Peña Nieto signed a measure into law that legalizes marijuana for research and medicinal purposes.
COLUMBUS, Ohio, June 20, 2017 /Weed Wire/ — Battelle announced today the expansion of its public health research center beyond tobacco to include research on the physical and behavioral effects of other substances, notably marijuana and opioids.
While Pennsylvania is processing hundreds of medical cannabis business applications, one private Pennsylvanian research university is already making plans to conduct a medical cannabis autism study.
Thanks to a 2% gain to 49 cents today, the Cann Group Ltd (ASX: CAN) share price has now risen over 63% since hitting the ASX boards.